ICD code J84.9 – Unspecified interstitial lung disease

Key takeaways

ICD-10 Code J84.9 is the billable code for interstitial pulmonary disease when the physician documents ILD without a specific type or fibrosis.

Query the treating physician before assigning J84.9, because documented IPF, NSIP, COP or fibrosis each has a more specific code.

Payers scrutinize unspecified codes, so the record needs HRCT findings, PFT results and a note on why the subtype can’t be named yet.

Drug-induced ILD (J70.2-J70.4) is an Excludes1 of J84, and hypersensitivity pneumonitis and sarcoidosis code to J67.- and D86.0 instead of J84.9.

Pabau’s claims management software works with the Claim.MD clearinghouse for eligibility checks, electronic claims and remittance tracking.

ICD-10 Code J84.9: Definition, billable status, and code hierarchy

ICD-10 Code J84.9 is a valid, billable ICD-10-CM diagnosis code with the official descriptor “Interstitial pulmonary disease, unspecified.”

It has been valid from FY 2016 through the current FY 2027 code set, as confirmed in the CDC/NCHS ICD-10-CM web tool. No 7th-character extension is required. The code sits at the end of the J84 category and applies only once every more specific subcode has been ruled out.

The CMS ICD-10-CM coding resources page publishes annual code files and the full tabular list. Coders should verify the code’s active status each October when new FY updates take effect. Neighboring respiratory codes such as J84.10 and J84.112 sit in our ICD-10-CM code library.

The J84 code family: How J84.9 relates to specific subcodes

J84.9 is the residual “unspecified” code at the end of the J84 category. The category spans J84.0 through J84.9, including J84.1x, J84.2 and J84.8x. Knowing where J84.9 sits relative to the specific subcodes is the fastest way to cut overuse of the unspecified code.

Work through the specific subcodes from the top down. ICD-10 Code J84.9 becomes the right assignment only when no specific subtype or fibrosis is documented and a physician query has been attempted.

Excludes notes, code-first conventions, and tabular list instructions

The J84 category carries Excludes1 and Excludes2 notes that govern when J84.9 applies and when it does not. Misreading it is a common reason coders assign J84.9 incorrectly.

Practical rule: Before assigning J84.9, check whether the documentation supports hypersensitivity pneumonitis (J67.-), pulmonary sarcoidosis (D86.0) or a drug-induced disorder (J70.2-J70.4). Drug-induced disorders are barred by the J84 Excludes1 note. Hypersensitivity pneumonitis and sarcoidosis code to J67.- and D86.0 because they are specific diagnoses, so J84.9 is not assigned for the same condition. Eosinophilic pneumonia sits in a separate category and codes to J82.81 or J82.82.

J84.9 vs specific ILD codes: When to use which

The ICD-10-CM Official Guidelines instruct coders to assign the most specific code supported by physician documentation. For ILD, that means working through the specific subtypes before defaulting to J84.9. The table below maps clinical scenarios to the correct code assignment.

Critical distinction: J84.10 (pulmonary fibrosis, unspecified) sits above J84.9 in specificity. If the physician has documented fibrosis, even without naming the subtype, J84.10 is the correct code. J84.9 is for ILD documented without a specified type or fibrosis.

Pick the pattern the physician documented in the picker below to see which code it supports.

Differential diagnosis codes often confused with J84.9

Several conditions present with ILD-like findings on HRCT but code to other categories. Assigning J84.9 when one of these is the correct diagnosis creates a coding error that payers flag on audit.

The American Thoracic Society’s official guidelines set the diagnostic criteria that separate IPF from hypersensitivity pneumonitis and other ILD subtypes. Those criteria decide whether J84.112 or J84.9 is the appropriate code.

Documentation requirements to support a J84.9 diagnosis

Payer medical necessity review for J84.9 centers on two questions. Does the record establish an ILD diagnosis? And does it explain why a more specific code cannot be assigned? Both must be answered in the clinical note rather than inferred from imaging results alone.

Documentation that supports J84.9 must include all of the following:

• Physician diagnosis statement: The treating physician must explicitly document “interstitial lung disease” or “interstitial pulmonary disease.” Coders cannot infer an ILD diagnosis from HRCT findings or PFT results alone.
• HRCT findings: High-resolution computed tomography (HRCT) report noting a pattern consistent with ILD (reticular opacities, honeycombing, ground-glass changes) supports the diagnosis. It also justifies the imaging codes 71250 and 71270.
• Pulmonary function test results: PFT results (spirometry, DLCO/diffusion capacity) documenting a restrictive pattern and reduced DLCO are standard supporting evidence. These also justify co-billed CPT codes 94010, 94060 and 94729.
• Statement explaining limited specificity: The note should state why a more specific subtype cannot be assigned. Examples include “awaiting surgical lung biopsy results,” “HRCT pattern indeterminate,” or “multidisciplinary discussion pending.”
• Exclusion of differential diagnoses: Showing that hypersensitivity pneumonitis, sarcoidosis, and drug-induced ILD were considered and excluded (or are pending workup) strengthens the J84.9 assignment.

Documentation pitfalls that drive denials

Radiologist impressions are not physician diagnoses. A chest CT report that reads “findings consistent with interstitial lung disease” does not constitute a physician-documented diagnosis of ILD. The treating physician must interpret and adopt that finding in their own note. Coders who assign J84.9 based solely on radiologist language are creating a documentation deficiency that payers audit actively.

Similarly, if the note says “idiopathic pulmonary fibrosis suspected” or “likely IPF,” that tentative language does not support J84.9. Per ICD-10-CM Official Guidelines, Section IV.H (outpatient uncertain diagnosis), “probable” and “suspected” diagnoses in outpatient settings cannot be coded as confirmed. The physician must state the diagnosis definitively, or the encounter codes to symptoms such as dyspnea (R06.0x) or abnormal lung imaging (R91.8). When the note records “shortness of breath” rather than dyspnea, the symptom code is R06.02.

Which CPT codes are commonly billed with ICD-10 Code J84.9

ICD-10 Code J84.9 supports a defined set of CPT services. Payers run edits that cross-check whether the procedure code is clinically appropriate for the diagnosis. An HRCT claim paired with an unrelated diagnosis fails those edits regardless of documentation quality. Use the AAPC Codify ICD-10-CM lookup to verify CPT-to-ICD-10 medical necessity crosswalks for each service.

When a lavage or biopsy names the pattern, recode the encounter to the specific J84 subcode. The lavage itself is reported with 31624, which carries its own documentation requirements.

Payer requirements and Medicare coverage for J84.9 claims

CMS and Medicare Administrative Contractors (MACs) publish Local Coverage Determinations (LCDs) for pulmonary services. No single national LCD covers J84.9 as the sole diagnosis. Coverage for pulmonary function testing, home oxygen and pulmonary rehabilitation follows each service’s own criteria, and J84.9 alone does not satisfy them. Claims management software with built-in eligibility checks helps surface LCD requirements before the claim is submitted.

Key payer requirements that commonly apply to J84.9 claims:

• Home oxygen (E0424, E1390): Medicare requires documented PaO2 or SpO2 thresholds. J84.9 alone does not guarantee coverage. The clinical record must meet the LCD’s oxygen qualifying criteria regardless of diagnosis code.
• Pulmonary rehabilitation (G0424): Medicare’s national coverage determination covers pulmonary rehab for moderate to very severe COPD. Coverage for ILD depends on the MAC, and J84.9 alone does not qualify.
• Nintedanib and pirfenidone: Plans typically require documented IPF in the prior authorization for these antifibrotic drugs. Nintedanib is also approved for SSc-ILD and progressive fibrosing ILD, so check each plan’s criteria. A request that carries only J84.9 should prompt a CDI query to the treating physician.
• Commercial payers: Commercial payers often flag unspecified codes during utilization review. Prior authorization requests with J84.9 for high-cost services (surgical biopsy, nintedanib) commonly trigger information requests. Expect to send HRCT reports, PFT results, and a physician statement of why a specific diagnosis is not yet established.

Common claim denial reasons for J84.9 and how to prevent them

J84.9 denials follow predictable patterns, so pre-submission edits can catch them before the claim reaches the payer. Our guide to denial management in healthcare covers the broader framework. The J84.9-specific triggers are below.

Clean claim submission standards require that the diagnosis code, procedure code, and documentation all align before the claim goes out. Our overview of clean claim submission standards covers the pre-submission checklist that reduces denial rates across code families.

CDI guidance: Querying for specificity beyond J84.9

The single highest-value action a CDI specialist can take on an ILD encounter is querying the treating physician before the code is assigned. A well-timed query that moves J84.9 to J84.112 (IPF) improves HCC risk adjustment accuracy and removes the unspecified-code flag from the claim. It also gives antifibrotic prior authorization requests the documented IPF that plans typically require.

When to query

Query before coding. CDI queries issued after the claim is submitted create a corrected-claim scenario that is both administratively burdensome and potentially subject to audit scrutiny. The optimal window is during the encounter or within the same encounter date before the claim goes out.

Trigger a physician query when any of the following appear in the chart:

• HRCT findings described as a UIP (usual interstitial pneumonia) pattern, which supports IPF and may warrant J84.112
• Prior BAL or surgical biopsy results showing a named histologic pattern (UIP, NSIP, DIP, RB-ILD)
• A documented connective tissue disease (RA, SSc, Sjogren’s, PM/DM) in a patient with ILD, coded per the tabular list for that CTD
• Physician notes that use terms like “likely IPF,” “probable fibrotic ILD,” or “consistent with pulmonary fibrosis,” which point to a diagnosis not yet formally stated

Sample query template for ILD specificity

Use this template as a starting point. AHIMA and AHA Coding Clinic guidance requires that queries be non-leading, offer multiple clinically supported options, and be documented in the medical record:

Patient: [Name/MRN] | Encounter: [Date]

The clinical documentation for this encounter includes HRCT findings of [describe pattern] and PFT results showing [describe]. To support accurate diagnosis coding, could you please clarify the specific diagnosis for this patient’s interstitial lung condition? Options include:

• (a) Idiopathic pulmonary fibrosis (J84.112)
• (b) Idiopathic non-specific interstitial pneumonitis (J84.113)
• (c) Non-specific interstitial pneumonia NOS, or due to a known cause (J84.89)
• (d) Cryptogenic organizing pneumonia (J84.116)
• (e) ILD associated with [named CTD] (code per tabular list)
• (f) Interstitial pulmonary disease, unspecified (J84.9), if specificity cannot be determined at this time
• (g) Unable to determine

Please document your response in the medical record.

This format follows AHIMA’s CDI query guidelines. It passes the non-leading test by presenting every clinically plausible option, including J84.9 and “unable to determine.”

ICD-10-CM coding guidelines for chronic interstitial lung disease

The ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.10 (Diseases of the Respiratory System), govern J84.9 assignment. Three guideline principles apply directly:

• Assign the most specific code supported by documentation. Section I.B of the guidelines directs coders to select the most specific code that accurately reflects the documented diagnosis. For ILD, this means working down the J84 subcode hierarchy before defaulting to J84.9.
• Outpatient uncertain diagnosis rule. Per ICD-10-CM Official Guidelines, Section IV.H (outpatient uncertain diagnosis), conditions documented as “probable,” “suspected,” or “likely” cannot be coded as confirmed. If the physician writes “suspected ILD,” code to the presenting symptoms (dyspnea R06.09, abnormal findings on chest imaging R91.8) rather than J84.9.
• Sequencing J84.9 as a secondary diagnosis. J84.9 may be coded as a secondary diagnosis when the encounter is mainly for a different condition. ILD then has to be a clinically relevant comorbidity managed during that visit. When J84.9 is secondary, sequence it after the principal diagnosis per standard sequencing rules.

How Pabau supports clean J84.9 claims

Without connected billing software, a pulmonology billing team checks eligibility on payer portals, keys each claim by hand and reconciles remittances separately. Every manual hand-off is a chance for an unspecified ILD claim to go out unchecked.

Pabau, the practice management and billing platform we build, connects to the Claim.MD clearinghouse. Your team runs insurance eligibility checks and submits electronic claims to the payers on Claim.MD’s list from the patient record.

Remittance tracking then shows which ILD claims came back denied. Your coders can query the physician and correct those claims while the encounter is still fresh.

Send cleaner ILD claims with Pabau

Pabau connects to the Claim.MD clearinghouse for eligibility checks, electronic claims and remittance tracking. Your team confirms coverage before J84.9 claims go out.

Book a demo

Conclusion

ICD-10 Code J84.9 is a legitimate billing code, but it carries more denial risk than any specific J84 subcode. Treat it as the answer to a physician query, never as a substitute for one.

Querying before coding moves the work from appeals back to the chart, where one line from the physician settles the code. The trade-off is a short delay before submission, which costs far less than a denied claim.

Pabau’s claims tools, connected to Claim.MD’s clearinghouse, support eligibility checks, electronic claims and remittance tracking for pulmonology billing teams. Book a demo to see how the claims workflow handles ILD coding scenarios.

Continue your research

Need a framework for handling denial codes across claim types? Denial codes in medical billing covers CARC and RARC code interpretation for building a systematic denial appeal process.

Looking to understand how ILD claims move through the revenue cycle? Revenue cycle management fundamentals explains how diagnosis codes, claim submission, and remittance processing connect.

Want to verify eligibility and reduce prior auth delays on pulmonary claims? Insurance eligibility verification details the pre-submission checks that prevent unnecessary rejections.

Frequently asked questions